LEE011
novartis
['breast', 'novartis']
patients with hr+/her2- #advancedbreastcancer and visceral metastases historically have a poor prognosis and poor overall survival. at #esmo22, learn more of how novartis will address these outcomes. 
Committed to providing medical & scientific disease education information to healthcare professionals. See our community guidelines: https://t.co/pj8hG1sQAu